Epidemiology of paediatric chronic fatigue syndrome in Australia.
Knight, Sarah, Elders, Shane, Rodda, Jill et al. · Archives of disease in childhood · 2019 · DOI
Quick Summary
This study looked at how many Australian children develop ME/CFS and what their experiences are like. Researchers tracked newly diagnosed cases over one year and found that the condition is quite rare in children under 10, but becomes more common in teenagers. Interestingly, the rates were very different depending on where children lived in Australia, suggesting some areas may be better at recognizing and diagnosing the condition than others.
Why It Matters
Understanding how common ME/CFS is in children and adolescents helps healthcare systems allocate resources appropriately and identify underdiagnosed populations. The striking regional differences suggest that many children may be missed or misdiagnosed due to poor access to specialists or lack of clinician awareness—highlighting the need for better training and more equitable care pathways.
Observed Findings
Estimated incidence in children aged 4-9 years was 0.25 per 100,000 per annum
Incidence in children aged 10-17 years varied markedly by state, with Victoria at 17.48 per 100,000 compared to 1.31-5.51 per 100,000 elsewhere
Most cases were female and Caucasian, with gradual symptom onset typically following an infectious illness
Median delay from symptom onset to diagnosis was at least 13 months
Management approaches, symptom severity, investigations, and associated features were highly variable across cases
Inferred Conclusions
CFS incidence in Australian children under 10 years is very low and consistent with international data
Incidence in adolescents aged 10-17 years is substantially higher but obscured by marked geographical variation, likely reflecting differences in service accessibility and clinician understanding rather than true disease variation
National initiatives are needed to improve equitable access to diagnosis and care for children with CFS across different regions
Remaining Questions
What is the true prevalence of ME/CFS in Australian children when including undiagnosed and non-paediatrician-diagnosed cases?
What specific factors in Victoria lead to higher diagnostic rates—specialist availability, clinician training, referral pathways, or other healthcare system features?
What This Study Does Not Prove
This study does not establish the true prevalence of ME/CFS in Australian children, only paediatrician-diagnosed cases—meaning the actual number of affected children is likely higher due to underdiagnosis and the reliance on specialist referral pathways. The regional variation does not prove differences in disease incidence; it more likely reflects differences in healthcare access, specialist availability, and clinician familiarity with the condition. The study also cannot determine causation for post-infectious presentation patterns.